HC stays Maharashtra govt's action against e-cigarette manufacturers

Image
Press Trust of India Mumbai
Last Updated : Aug 02 2019 | 8:10 PM IST

The Bombay High Court on Friday stayed the Maharashtra government's action against e-cigarette manufacturers.

A division bench of Justices Ranjit More and Bharati Dangre was hearing a petition filed by e-cigarette manufacturer Godfrey Philips India Ltd and its director Sharad Aggarwal, challenging the Maharashtra Food and Drug Administration (FDA) move to seize e-cigarettes claiming that it was banned in the state.

While staying the government's action, the bench directed the Centre to spell out its stand on whether e-cigarettes was a drug and hence banned.

The company is in the business of import, storage, distribution and sale of Electronic Nicotine Delivery Systems (ENDS), popularly called e-cigarettes.

As per its plea, e-cigarettes are allowed to be sold and used by the public throughout the world and is considered "a less harmful and safer substitute" to smoking tobacco cigarettes.

According to the company, the use of e-cigarettes in India came up for discussion before the Drugs Consultative Committee in its 48th meeting in July 2015 and it was recommended that the product is not covered under the definition of the term 'drug' and hence does not come under the purview of the Drugs and Cosmetics Act.

Also Read

On August 28, 2018, the Union government issued an advisory to all the state governments to ban the production, storage, sale and distribution of e-cigarettes.

Based on this circular, on March 5 this year, Maharashtra state FDA Commissioner had issued a direction to its enforcement officers to ban the storage, manufacture, sale and distribution of e-cigarettes in the state.

On June 25 this year, the FDA carried out searches in the office and warehouse of the petitioner company at various places in the state, and seized their products.

The FDA on July 6 issued a show-cause notice to the company for violation of the Cigarettes and Other Tobacco Products Act and the Drug and Cosmetics Act.

The company's counsel Amit Desai had earlier argued that the Delhi High Court in November 2018, while hearing a petition challenging the government's August 28, 2018 advisory, had said in its order that the advisory was non-binding on the state governments.

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Aug 02 2019 | 8:10 PM IST

Next Story